Protein misfolding and medicinal strategies in neurodegenerative disorders

被引:0
|
作者
Mehboudi, Leila [1 ]
Zahedirad, Mehrshad [2 ]
Vadiei, Parisa [2 ]
机构
[1] Jahrom Univ Med Sci, Fac Med, Dept Anesthesia, Jahrom, Iran
[2] Islamic Azad Univ, Dept Med Lab, Chalus Branch, Fac Paramed Sci, Chalus, Iran
来源
MEDICINA BALEAR | 2022年 / 37卷 / 04期
关键词
Protein misfolding; Alzheimer's disease; Huntington's disease; Parkinson's disease; THERAPEUTIC STRATEGIES; DISEASES;
D O I
10.3306/AJHS.2022.37.04.166
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Proteins that misfold may accumulate and cause disorders like Alzheimer's and Parkinson's. New medicines are also explored to forecast and even cure these illnesses' severe symptoms. Because they were misfolded during creation or maintenance, rogue proteins may harm a biological system. This causes over twenty human illnesses, including Alzheimer's, Huntington's, Parkinson's, and other neurodegenerative diseases. To create new therapies and medications, researchers will need to understand protein misfolding and aggregation formation. To summarize, protein misfolding causes aggregation and neurodegeneration. This suggests that nature employs protein aggregation to execute unique physiological activities in various biological conditions.
引用
收藏
页码:166 / 170
页数:5
相关论文
共 50 条
  • [41] A comprehensive review of protein misfolding disorders, underlying mechanism, clinical diagnosis, and therapeutic strategies
    Basha, Shaik
    Mukunda, Darshan Chikkanayakanahalli
    Rodrigues, Jackson
    DSouza, Meagan Gail
    Gangadharan, Gireesh
    Pai, Aparna Ramakrishna
    Mahato, Krishna Kishore
    AGEING RESEARCH REVIEWS, 2023, 90
  • [42] Challenges and limitations in computational prediction of protein misfolding in neurodegenerative diseases
    Krokidis, Marios G.
    Dimitrakopoulos, Georgios N.
    Vrahatis, Aristidis G.
    Exarchos, Themis P.
    Vlamos, Panagiotis
    FRONTIERS IN COMPUTATIONAL NEUROSCIENCE, 2024, 17
  • [43] Context Dependence of Protein Misfolding and Structural Strains in Neurodegenerative Diseases
    Mehta, Anil K.
    Rosen, Rebecca F.
    Childers, W. Seth
    Gehman, John D.
    Walker, Lary C.
    Lynn, David G.
    BIOPOLYMERS, 2013, 100 (06) : 722 - 730
  • [44] Inflammatory mediators leading to protein misfolding and uncompetitive/fast off-rate drug therapy for neurodegenerative disorders
    Lipton, Stuart A.
    Gu, Zezonq
    Nakamura, Tomohiro
    NEUROINFLAMMATION IN NEURONAL DEATH AND REPAIR, 2007, 82 : 1 - 27
  • [45] Amyloid aggregates: role in protein misfolding disorders
    Duran-Aniotz, Claudia
    Moreno-Gonzalez, Ines
    Morales, Rodrigo
    REVISTA MEDICA DE CHILE, 2013, 141 (04) : 495 - 505
  • [46] Protein misfolding and disease: the case of prion disorders
    Hetz, C
    Soto, C
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2003, 60 (01) : 133 - 143
  • [47] Visual aspects of neurologic protein misfolding disorders
    Pula, John H.
    Kim, Jisoon
    Nichols, Jeffrey
    CURRENT OPINION IN OPHTHALMOLOGY, 2009, 20 (06) : 482 - 489
  • [48] Protein misfolding and disease: the case of prion disorders
    C. Hetz
    C. Soto
    Cellular and Molecular Life Sciences CMLS, 2003, 60 : 133 - 143
  • [49] Discovering Traditional Chinese Medicinal Herbs for Neurodegenerative Disorders
    Liu, Xuewei
    Jia, Caixia
    Wu, Chuanhong
    Wang, Na
    Jia, Yongming
    Zhu, Yongtao
    Li, Pengyue
    Ghulam, Murtaza
    Zhang, Kunlin
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 82 : 70 - +
  • [50] Cell replacement strategies for neurodegenerative disorders
    Björklund, A
    NEURAL TRANSPLANTATION IN NEURODEGENERATIVE DISEASE: CURRENT STATUS AND NEW DIRECTIONS, 2000, 231 : 7 - 15